Immunity in Neonates and Infants (U01)

Post Date

March 7th 2016

Application Due Date

July 29th 2016

Funding Opportunity Number

RFA-AI-16-001

CFDA Number(s)

93.113
93.313
93.855
93.856
93.865

Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Environment
Health
Income Security and Social Services

Eligibility Categories

State Governments
County Governments
City or Township Governments
Special District Governments
Independent School Districts
Public and State Controlled Institutions of Higher Education
Federally Recognized Native American Tribal Governments
Public Housing Authorities or Indian Housing Authorities
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Funding

• Estimated Total Funding:

  $8000500

• Award Range:

  $None - $None

Grant Description

This Funding Opportunity Announcement (FOA) invites applications from institutions and organizations to participate in a cooperative research group, focusing on elucidating mechanisms regulating the development and function of the immune system in neonates (0-28 days) and infants (29 days 12 months), including immune mechanisms triggered by non-pathogenic or pathogenic microbes (including HIV), vaccines, exposure to allergens, or alterations in immune function due to environmental exposures to pollutants. The purpose of this FOA is to advance current knowledge of the developing immune system during the first year of life and to encourage innovative approaches to more fully understand the distinct characteristics of neonatal/infant immune responses. Better understanding of infant and neonatal immune development has the potential to improve public health by providing a foundation for guiding the maturation of a healthy (protective) immune system and reducing the development of immune-mediated disorders, reducing susceptibility to infections and allergens, and improving immune responses to vaccines in these vulnerable populations.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-16-001.html